SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-05-004679
Filing Date
2005-02-09
Accepted
2005-02-08 18:29:18
Documents
4
Period of Report
2005-02-03
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a05-3064_18k.htm 8-K 38391
2 EX-10.1 a05-3064_1ex10d1.htm EX-10.1 16220
3 EX-10.2 a05-3064_1ex10d2.htm EX-10.2 15967
4 EX-10.3 a05-3064_1ex10d3.htm EX-10.3 16666
  Complete submission text file 0001104659-05-004679.txt   89228
Mailing Address
Business Address 130 WAVERLY STREET CAMBRIDGE MA 02139-4242 6165776000
VERTEX PHARMACEUTICALS INC / MA (Filer) CIK: 0000875320 (see all company filings)

IRS No.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19319 | Film No.: 05585499
SIC: 2834 Pharmaceutical Preparations